chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 31.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Laboratory test normal, Palpitations, Pericarditis, Post vaccination syndrome, QRS axis abnormal
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference 414380. A 31-year-old female patient had received the following vaccination on 06 June 2010:  ACAM2000 (lot number not reported), and an unspecified amount of time later, experienced angina pectoris and palpitations. The patient reported to have had intermittent brief episodes of sharp "heart pains" and palpitations that lasted for three minutes at its longest duration. She reported that she could resolve them with sitting upright, leaning forward or standing upright and deep breathing. The patient denies dyspnea, nausea and vomiting (n/v), diaphoresis, history of same, family history of same, abdominal pain, fevers, chills, or recent illness. The patient was given the diagnosis of "suspect post vaccinia pericarditis" by the working group. Laboratory data included a normal cardiac enzyme, an electrocardiogram that showed a normal sinus rhythm with inverted T wave in AVR and V-1, Right axis deviation, a normal red blood cell sedimentation rate of 6, a CBC within normal limits, a general chemistry within normal limits and a negative UDS. Concomitant medications included doxycycline for malaria prevention. The patient was evaluated in the emergency room. No further information was available at the time of the report. The patient's outcome was reported as recovered on an unspecified date. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Age: 31.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Red blood cell sedimentation rate normal
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference 414380. A 31-year-old female patient had received the following vaccination on 06 June 2010:  ACAM2000 (lot number not reported), and an unspecified amount of time later, experienced angina pectoris and palpitations. The patient reported to have had intermittent brief episodes of sharp "heart pains" and palpitations that lasted for three minutes at its longest duration. She reported that she could resolve them with sitting upright, leaning forward or standing upright and deep breathing. The patient denies dyspnea, nausea and vomiting (n/v), diaphoresis, history of same, family history of same, abdominal pain, fevers, chills, or recent illness. The patient was given the diagnosis of "suspect post vaccinia pericarditis" by the working group. Laboratory data included a normal cardiac enzyme, an electrocardiogram that showed a normal sinus rhythm with inverted T wave in AVR and V-1, Right axis deviation, a normal red blood cell sedimentation rate of 6, a CBC within normal limits, a general chemistry within normal limits and a negative UDS. Concomitant medications included doxycycline for malaria prevention. The patient was evaluated in the emergency room. No further information was available at the time of the report. The patient's outcome was reported as recovered on an unspecified date. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Age: 31.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Angina pectoris, Cardiac enzymes normal, Drug screen negative, Electrocardiogram T wave inversion, Electrocardiogram abnormal
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference 414380. A 31-year-old female patient had received the following vaccination on 06 June 2010:  ACAM2000 (lot number not reported), and an unspecified amount of time later, experienced angina pectoris and palpitations. The patient reported to have had intermittent brief episodes of sharp "heart pains" and palpitations that lasted for three minutes at its longest duration. She reported that she could resolve them with sitting upright, leaning forward or standing upright and deep breathing. The patient denies dyspnea, nausea and vomiting (n/v), diaphoresis, history of same, family history of same, abdominal pain, fevers, chills, or recent illness. The patient was given the diagnosis of "suspect post vaccinia pericarditis" by the working group. Laboratory data included a normal cardiac enzyme, an electrocardiogram that showed a normal sinus rhythm with inverted T wave in AVR and V-1, Right axis deviation, a normal red blood cell sedimentation rate of 6, a CBC within normal limits, a general chemistry within normal limits and a negative UDS. Concomitant medications included doxycycline for malaria prevention. The patient was evaluated in the emergency room. No further information was available at the time of the report. The patient's outcome was reported as recovered on an unspecified date. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Age: 31.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Full blood count normal, Laboratory test normal, Palpitations, Pericarditis, QRS axis abnormal
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference 414380. A 31-year-old female patient had received the following vaccination on 06 June 2010:  ACAM2000 (lot number not reported), and an unspecified amount of time later, experienced angina pectoris and palpitations. The patient reported to have had intermittent brief episodes of sharp "heart pains" and palpitations that lasted for three minutes at its longest duration. She reported that she could resolve them with sitting upright, leaning forward or standing upright and deep breathing. The patient denies dyspnea, nausea and vomiting (n/v), diaphoresis, history of same, family history of same, abdominal pain, fevers, chills, or recent illness. The patient was given the diagnosis of "suspect post vaccinia pericarditis" by the working group. Laboratory data included a normal cardiac enzyme, an electrocardiogram that showed a normal sinus rhythm with inverted T wave in AVR and V-1, Right axis deviation, a normal red blood cell sedimentation rate of 6, a CBC within normal limits, a general chemistry within normal limits and a negative UDS. Concomitant medications included doxycycline for malaria prevention. The patient was evaluated in the emergency room. No further information was available at the time of the report. The patient's outcome was reported as recovered on an unspecified date. Note: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Documents held by sender: none.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Blood creatine phosphokinase increased, Chest pain, Echocardiogram normal, Electrocardiogram ST segment elevation, Myopericarditis
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414522. A 24-year-old male patient received the following vaccination on 03 January 2011: ACAM2000 (lot number VV04003A). On 12 January 2011, nine days post vaccination, the patient arrived at the emergency department with chest pain. An ECG demonstrated diffuse ST elevation consistent with pericarditis. Cardiac biomarkers included elevated CK and troponin which confirmed myopericarditis and the patient was hospitalized. The patient had no concurrent illness and no past medical history. Outcome was unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Troponin increased
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414522. A 24-year-old male patient received the following vaccination on 03 January 2011: ACAM2000 (lot number VV04003A). On 12 January 2011, nine days post vaccination, the patient arrived at the emergency department with chest pain. An ECG demonstrated diffuse ST elevation consistent with pericarditis. Cardiac biomarkers included elevated CK and troponin which confirmed myopericarditis and the patient was hospitalized. The patient had no concurrent illness and no past medical history. Outcome was unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Chest pain, Dyspnoea, Pericarditis
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414522. A 24-year-old male patient received the following vaccination on 03 January 2011: ACAM2000 (lot number VV04003A). On 12 January 2011, nine days post vaccination, the patient arrived at the emergency department with chest pain. An ECG demonstrated diffuse ST elevation consistent with pericarditis. Cardiac biomarkers included elevated CK and troponin which confirmed myopericarditis and the patient was hospitalized. The patient had no concurrent illness and no past medical history. Outcome was unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Blood creatine phosphokinase increased, Chest pain, Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Myopericarditis
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414522. A 24-year-old male patient received the following vaccination on 03 January 2011: ACAM2000 (lot number VV04003A). On 12 January 2011, nine days post vaccination, the patient arrived at the emergency department with chest pain. An ECG demonstrated diffuse ST elevation consistent with pericarditis. Cardiac biomarkers included elevated CK and troponin which confirmed myopericarditis and the patient was hospitalized. The patient had no concurrent illness and no past medical history. Outcome was unknown. Documents held by sender: None.
Age: 24.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Pericarditis, Troponin increased
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414522. A 24-year-old male patient received the following vaccination on 03 January 2011: ACAM2000 (lot number VV04003A). On 12 January 2011, nine days post vaccination, the patient arrived at the emergency department with chest pain. An ECG demonstrated diffuse ST elevation consistent with pericarditis. Cardiac biomarkers included elevated CK and troponin which confirmed myopericarditis and the patient was hospitalized. The patient had no concurrent illness and no past medical history. Outcome was unknown. Documents held by sender: None.
Age: 59.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blister, Erythema, Rash pustular
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414558. A 59 year-old male patient received the following vaccination on 25 August 2010: ACAM2000 (lot number VV04-003-A). Fifty-one days after receiving the inoculation, the patient had the usual course of events for smallpox vaccination with formulation of pustule with drainage and usual care was provided; however scab never formed and residual area of erythema with small vesicles remained 5 months after inoculation. Laboratory data included biopsy of area at the hospital on 18 January 2011. Patient's medical history includes thoracic outlet syndrome (left side) with mild residual weakness of left arm; hypercholesterolemia; and BPH (benign prostate hypertrophy). Other medications included LIPITOR, and "finisteride". Documents held by sender: None.
Age: 59.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Biopsy skin, Injection site erythema, Injection site vesicles, Laboratory test
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414558. A 59 year-old male patient received the following vaccination on 25 August 2010: ACAM2000 (lot number VV04-003-A). Fifty-one days after receiving the inoculation, the patient had the usual course of events for smallpox vaccination with formulation of pustule with drainage and usual care was provided; however scab never formed and residual area of erythema with small vesicles remained 5 months after inoculation. Laboratory data included biopsy of area at the hospital on 18 January 2011. Patient's medical history includes thoracic outlet syndrome (left side) with mild residual weakness of left arm; hypercholesterolemia; and BPH (benign prostate hypertrophy). Other medications included LIPITOR, and "finisteride". Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Chest pain, Circumoral oedema, Electrocardiogram T wave inversion, Oropharyngeal pain, Pruritus
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Rash, Rash generalised
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Chest pain, Circumoral oedema, Electrocardiogram ST segment normal, Electrocardiogram T wave inversion, Oropharyngeal pain
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Pruritus, Rash, Rash generalised
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Asthenia, Cardiac stress test abnormal, Cardiovascular examination, Chest discomfort, Dyspnoea
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Echocardiogram normal, Ejection fraction normal, Electrocardiogram ST segment normal, Electrocardiogram T wave inversion, Electrocardiogram abnormal
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Exercise tolerance decreased, Pain, Palpitations, Pharyngeal erythema, Radioisotope scan
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Rash, Rash generalised, Rash maculo-papular, Rash pruritic, Single photon emission computerised tomogram normal
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 33.0
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Sinus rhythm, Supraventricular extrasystoles, Throat irritation, Troponin normal, Ventricular extrasystoles
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414584. A 33 year-old male patient received the following vaccination on 03 November 2010: ACAM2000 (lot number V004-003-A). Ten days after inoculation, the patient developed rash with pruritis on his hands and was given BENADRYL for the pruritis. Thirty-one days later, he developed generalized rash, perioral edema, and sore throat and was admitted to the hospital where he received intravenous steroids, ATARAX, TYLENOL and prophylactic antibiotics. There was possible pericarditis associated with the chest pain on 16 November 2010 that resolved. Treatment included INDOCIN and aspirin. Date of discharge from the hospital was not reported. Laboratory data included EKG that revealed inverted T-waves, but no significant ST changes. The patient had no other current illnesses or medical history, but was taking MOTRIN at time of the events. Patient recovered. Documents held by sender: None.
Age: 34.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Abscess, Bacterial infection, Incisional drainage, Injection site erythema, Pyrexia
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414987. A 34-year-old male patient received the following vaccinations on 13 June 2010: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B1026), BIOTHRAX (lot number FAV223). On 30 June 2010, 17 days post-vaccination, the patient developed fever and redness at the vaccination site. The patient also developed a secondary bacterial infection with abscess formation and sepsis and was hospitalized for five days (dates not reported). Corrective treatments consisted of parenteral antibiotics and incision and drainage. The patient had no concurrent illness, no past history and no prior vaccinations. Outcome was recovered. Documents held by sender: None.
Age: 34.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Sepsis
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414987. A 34-year-old male patient received the following vaccinations on 13 June 2010: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number B1026), BIOTHRAX (lot number FAV223). On 30 June 2010, 17 days post-vaccination, the patient developed fever and redness at the vaccination site. The patient also developed a secondary bacterial infection with abscess formation and sepsis and was hospitalized for five days (dates not reported). Corrective treatments consisted of parenteral antibiotics and incision and drainage. The patient had no concurrent illness, no past history and no prior vaccinations. Outcome was recovered. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Blood creatine phosphokinase increased, Chest pain, Computerised tomogram thorax abnormal, Dyspnoea, Electrocardiogram normal
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Hilar lymphadenopathy, Injection site pain, Laboratory test normal, Lymphadenopathy, Musculoskeletal chest pain
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Myositis, Resuscitation, Tenderness, Troponin
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Blood creatine phosphokinase increased, Inflammation, Laboratory test normal, Myositis, Pain in extremity
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Troponin
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Blood gases, Cardiac enzymes, Chest X-ray, Chest discomfort, Chest pain
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Dyspnoea, Electrocardiogram, Full blood count, Laboratory test
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Blood creatine phosphokinase increased, Blood gases normal, Chest X-ray normal, Chest pain, Computerised tomogram abnormal
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Dyspnoea, Electrocardiogram normal, Hilar lymphadenopathy, Injection site pain, Lymphadenopathy
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Mediastinal disorder, Myositis, Tenderness, Troponin normal
Clinical narrative: Initial report received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 414996. A 20 year-old male patient received the following vaccination on 05 January 2011: ACAM2000 (lot number VV04-003-A). Approximately 7 days later on 11 January 2011, the patient was admitted for CT of the chest and further evaluation after transfer for right sided anterolateral chest pain associated with right upper extremity pain (injection site pain) and dyspnea that began 2-3 days prior. Notably he received a smallpox vaccination approximately 8 days prior to symptom onset and had persistent pain at the inoculation site on the right upper extremity. The patient had been seen twice in the clinic with normal ABG (arterial blood gas), Labs, CXR (chest x-ray), and EKG (electrocardiogram). On examination he was exquisitely tender over the right anterolateral chest wall. Labs and EKG were unremarkable aside from CK (creatine phosphokinase) of 684 with normal Troponin. The CK peaked at 505 over the next several days and with aggressive resuscitation with intravenous fluids the CK trended downward, but was 2422 at time of discharge. A CT of the chest showed no pulmonary embolus, but did reveal right axillary and hilar lymphadenopathy with mediastinal stranding. During his hospital course he remained afebrile without leukocytosis. At the time of discharge (date not reported), the patient was completely pain free and asymptomatic. It was suspected that his constellation of symptoms represented a localized chest wall myositis and reactive lymphadenopathy secondary to the smallpox vaccination; as there did not appear to be other attributable causes. Recommendations were made for a follow-up in approximately 2 months with CT of the chest with contrast to ensure resolution of the above findings; as well as repeat CK in several days time to ensure normalization. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Rash generalised, Rash pruritic, Rash pustular
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 415092. A 21-year-old male patient, who had no current illnesses and no medical history, received on 11 January 2011 a left arm percutaneous injection of ACAM2000 (invalid lot number VBC4003A). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 19 January 2011, 8 days after vaccination, the patient developed diffuse pruritic pustular rash over entire body which required an Emergency Visit. The patient was admitted to the hospital. The outcome was reported as recovered. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL
Symptoms: Injection site cellulitis, Rash erythematous
Clinical narrative: This case was received on 18 March 2011 via a third party query tool search on the VAERS database, under reference number 415110. A 20-year-old male patient, who had no current illnesses and no medical history, received on 10 January 2011 a left arm percutaneous injection of ACAM2000 (invalid lot number DVO1C01). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 19 January 2011, 9 days after vaccination, the patient developed noticeable 2 red "dots" on his right wrist with progression to body wide "red dots" by the end of the day. There was no pruritus and no drainage. The patient also had cellulitis extending from the site of smallpox vaccine which was approximately 9 centimeters by 5 centimeters. The patient was seen in the Emergency Room and was treated with 1 gram of vancomycin and 1 gram of ANCEF. The patient was sent home with SEPTRA and prednisone. The patient had no laboratory testing performed since the diagnosis was made on physical exam. The patient was later instructed at the "BAS" not to take the prednisone. The outcome was reported as recovered. Documents held by sender: None.